These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1712337

  • 1. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.
    Francavilla A, Starzl TE, Barone M, Zeng QH, Porter KA, Zeevi A, Markus PM, van den Brink MR, Todo S.
    Hepatology; 1991 Jul; 14(1):140-3. PubMed ID: 1712337
    [Abstract] [Full Text] [Related]

  • 2. Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.
    Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE.
    Lancet; 1989 Nov 25; 2(8674):1248-9. PubMed ID: 2479802
    [Abstract] [Full Text] [Related]

  • 3. FK 506 as a growth control factor.
    Francavilla A, Barone M, Starzl TE, Zeevi A, Scotti C, Carrieri G, Mazzaferro V, Prelich J, Todo S, Eiras G.
    Transplant Proc; 1990 Feb 25; 22(1):90-2. PubMed ID: 1689912
    [No Abstract] [Full Text] [Related]

  • 4. Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin.
    Chávez R, Jamieson N, Takamori S, Nivatvongs S, Pino G, Metcalfe A, Watson C, Romero D, Metcalfe S.
    Transplant Proc; 1999 Sep 25; 31(6):2429. PubMed ID: 10500655
    [No Abstract] [Full Text] [Related]

  • 5. FK506 promotes liver regeneration by suppressing natural killer cell activity.
    Tamura F, Masuhara A, Sakaida I, Fukumoto E, Nakamura T, Okita K.
    J Gastroenterol Hepatol; 1998 Jul 25; 13(7):703-8. PubMed ID: 9715421
    [Abstract] [Full Text] [Related]

  • 6. Liver regeneration during immunosuppression.
    Coughlin JP, Austen WG, Donahoe PK, Russell WE.
    J Pediatr Surg; 1987 Jun 25; 22(6):566-70. PubMed ID: 3612448
    [Abstract] [Full Text] [Related]

  • 7. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M, Stepień-Sopniewska B, Lagodziński Z, Górski A.
    Immunopharmacology; 1990 Jun 25; 20(1):57-61. PubMed ID: 1699911
    [Abstract] [Full Text] [Related]

  • 8. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
    Beck Y, Akiyama N.
    Transplant Proc; 1989 Jun 25; 21(3):3464-7. PubMed ID: 2472695
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced liver regeneration in rats treated with 15-deoxyspergualin alone and in combination with FK 506.
    Ohtake M, Okamura N, Sakaguchi T, Aono T, Koyama S, Tsukada K, Yoshida K, Muto T.
    Gastroenterol Jpn; 1993 Apr 25; 28(2):249-53. PubMed ID: 7683616
    [Abstract] [Full Text] [Related]

  • 10. Studies of the hepatotrophic qualities of FK 506 and CyA.
    Mazzaferro V, Scotti-Foglieni CL, Porter KA, Trejo Bellido J, Carrieri G, Todo S, Fung JJ, Francavilla A, Starzl TE.
    Transplant Proc; 1990 Feb 25; 22(1):93-5. PubMed ID: 1689913
    [No Abstract] [Full Text] [Related]

  • 11. Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro.
    Wasik M, Gorski A, Stepien-Sopniewska B, Lagodzinski Z.
    Transplantation; 1991 Jan 25; 51(1):268-70. PubMed ID: 1702910
    [Abstract] [Full Text] [Related]

  • 12. Effect of cyclosporin A on hepatocyte proliferation after partial hepatectomy in rats: comparison with standard immunosuppressive agents.
    Kim YI, Salvini P, Auxilia F, Calne RY.
    Am J Surg; 1988 Feb 25; 155(2):245-9. PubMed ID: 3341550
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of hepatocyte proliferation by immunosuppressant pretherapy is associated with up-regulation of malondialdehyde production.
    Kim YI, Kobayashi M, Egashira T, Kawano K, Morimoto A, Kai T, Shimada T.
    Res Exp Med (Berl); 1993 Feb 25; 193(5):337-45. PubMed ID: 7506444
    [Abstract] [Full Text] [Related]

  • 14. Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase.
    Vincent SH, Wang RW, Karanam BV, Klimko M, Alvaro R, Chiu SH.
    Biochem Pharmacol; 1991 May 01; 41(9):1325-30. PubMed ID: 1708254
    [Abstract] [Full Text] [Related]

  • 15. A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450.
    Yoshimura R, Yoshimura N, Kusunose E, Hamashima T, Ohsaka Y, Kusunose M, Oka T, Kishimoto T, Maekawa M.
    Transplant Proc; 1991 Feb 01; 23(1 Pt 1):311-3. PubMed ID: 1703686
    [No Abstract] [Full Text] [Related]

  • 16. The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels.
    Jacobs TW, Katz IA, Joffe II, Stein B, Takizawa M, Epstein S.
    Transplant Proc; 1991 Dec 01; 23(6):3188-9. PubMed ID: 1721403
    [No Abstract] [Full Text] [Related]

  • 17. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH.
    J Immunol; 1990 Jan 01; 144(1):251-8. PubMed ID: 1688572
    [Abstract] [Full Text] [Related]

  • 18. FK 506: an immunosuppressant for the 1990s?
    Macleod AM, Thomson AW.
    Lancet; 1991 Jan 05; 337(8732):25-7. PubMed ID: 1702172
    [Abstract] [Full Text] [Related]

  • 19. Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506.
    Tanaka N, Yamamoto H, Tatemoto A, Urabe T, Orita K.
    Int J Immunopharmacol; 1993 Feb 05; 15(2):211-8. PubMed ID: 7682200
    [Abstract] [Full Text] [Related]

  • 20. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS, Boltz RC, Siekierka JJ, Sigal NH.
    Cell Immunol; 1991 Apr 01; 133(2):269-84. PubMed ID: 1707760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.